-6%

est. 2Y upside i

FinTechSeries A

Making private healthcare in India accessible and affordable

Rank

#3684

Sector

Fintech

Est. Liquidity

~7Y

Data Quality

Data: Low

SaveIN carries a negative probability-weighted expected return of roughly -6% over a 2-year horizon, driven primarily by its alarming 2.5% YoY revenue growth on just $1.85M in revenue after 5 years and $12.9M raised.

Last updated: May 13, 2026

Bull (15%)+280%

SaveIN re-accelerates to 40%+ YoY growth, scales its provider network well beyond 10,000 clinics, reaches $8-10M revenue by 2028, and raises a Series B at roughly $80-100M post-money (~9-10x revenue). Common stockholders clear the $12.9M preference stack and see meaningful appreciation, but a 7-year runway to liquidity compresses the IRR substantially.

Base (45%)-35%

Growth edges up to 10-15% YoY from the current 2.5%, reaching roughly $2.5-3M revenue by 2028; the company raises a flat or modest-step-up round that extends runway but adds further dilution. Against an estimated ~$18M current valuation with $12.9M in senior liquidation preferences consuming ~72% of equity value, common shares retain minimal residual worth.

Bear (40%)-82%

The near-stagnant 2.5% YoY growth persists, runway burns out before a viable Series B can be raised on acceptable terms, and the company is sold in a distressed process or wound down. With $12.9M in preferences ahead of common stock, employees recover close to nothing from any sub-$20M exit.

Est. time to liquidity~7.0 years

Preference Stack Risk

severe

Funding Intensity

72%

Total liquidation preferences of $12.9M sit ahead of common stock against an estimated post-money valuation of approximately $18M, meaning senior preferences consume roughly 72% of current estimated equity value before any common dollar is returned.

Dilution Risk

high

A Series A company with sub-3% growth will need at least one or two additional funding rounds before any liquidity event, likely diluting common holders by a further 30-50% in aggregate.

Secondary Liquidity

none

No secondary market activity has been identified for a 59-person India-based Series A fintech; liquidity is entirely dependent on a future acquisition or IPO, neither of which appears imminent given current growth trajectory.

Questions to Ask at the Interview

Strategic questions based on SaveIN's data — designed to show you've done your homework.

  • 1

    “What is the current monthly GMV run-rate and net take-rate, and what specific product or distribution changes does the team believe will re-accelerate growth from 2.5% YoY to a Series B-worthy 50%+ trajectory?”

  • 2

    “With $12.9M raised and the company unprofitable, what is the current cash runway and what revenue or margin milestones must be hit to raise a Series B at a meaningful valuation step-up from the current round?”

  • 3

    “What is the equity grant structure (RSUs vs. options), current strike price or FMV per the most recent 409A-equivalent valuation, and what is the vesting cliff and acceleration policy on acquisition?”

Community

Valuation Sentiment

Our model estimates -6% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.